Brief: Alligator Bioscience Q3 Operating Result Turns To Loss of SEK 52.7 Mln
26/10/2023 07:24
Oct 26 (Reuters) - Alligator Bioscience AB ATORX.ST :
* Q3 NET SALES SEK 19.4 MILLION VERSUS SEK 5.1 MILLION YEAR
AGO
* Q3 OPERATING LOSS SEK 52.7 MILLION VERSUS SEK 51.2 MILLION
YEAR
AGO
Source text for Eikon: ID:nMFN4x8t3L
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln